The first stop for professional medicines advice

Medicine

313 results

Applied filters

Colistimethate sodium: informing intrathecal risk assessment

11 August 2022Colistimethate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Topotecan: informing intrathecal risk assessment

11 August 2022Topotecan products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Fluorescein: informing intrathecal risk assessment

11 August 2022Fluorescein products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Hydrocortisone acetate: informing intrathecal risk assessment

11 August 2022Hydrocortisone acetate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Cytarabine: informing intrathecal risk assessment

11 August 2022Cytarabine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Bupivacaine: informing intrathecal risk assessment

11 August 2022Bupivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Trastuzumab: informing intrathecal risk assessment

11 August 2022Trastuzumab products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Levobupivacaine: informing intrathecal risk assessment

11 August 2022Levobupivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Vancomycin: informing intrathecal risk assessment

11 August 2022Vancomycin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Amikacin: informing intrathecal risk assessment

11 August 2022Amikacin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration